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Abstract
Background: An alveolar cleft commonly affects 75% of cleft lip and palate patients. While it is common practice
to provide a course of orthodontic treatment before alveolar bone grafting, there are no previous high-quality
studies reporting on the benefits of this type of treatment.
Aim: The aim of the study is to evaluate the effectiveness of pre-alveolar bone graft orthodontics for unilateral non-
syndromic cleft palate patients.
Method: The PABO trial is a multicentric, parallel, two-arm, single-blinded randomised controlled trial. The inclusion
criteria include unilateral cleft alveolus patients requiring bone graft and between the age group of 8 and 13 years
with erupted upper central incisors. Participants will be recruited at three centres across India. Participants will be
randomised to orthodontic treatment or no orthodontic treatment group. Both groups of participants will have
alveolar bone graft surgery and will be followed up for 6 months after surgery. The primary outcome will be the
success of the alveolar bone graft measured by anterior oblique radiograph and secondary outcomes include
quality of life, cost analysis and quality of the dento-occlusal outcome. Data analysis will be carried out by an
independent statistician at the end of the study.
Discussion: This study is the first to evaluate the effect of orthodontics on alveolar bone graft success. The
increased burden of care for these patients with multiple treatments required from multiple specialists from birth to
adult life highlights the need for reducing unnecessary treatment provision.
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Background
Cleft lip and palate (CLP) are among the most common
congenital malformations with an overall incidence of
around 1 in 700 individuals newborns [1], and as a
result, between 27,000 and 33,000 children in India are
born with clefts every year [2]. CLP is accompanied by a
wide variety of dental and skeletal anomalies, which
have a long-term impact on the patient’s facial aesthet-
ics, function and self-esteem. CLP affects a range of ana-
tomical areas, and the optimal management of a child
with cleft demands an organised multidisciplinary effort
involving otolaryngology, plastic surgery, maxillofacial
surgery, orthodontics, speech and language therapy,
audiology, paediatrics, nursing, genetics, psychology, and
social work. Despite general progress in medical care,
cleft lip and palate and related craniofacial anomalies
have largely remained ‘orphan’ conditions, falling be-
tween several main disciplines. Treatment provision
lacks a firm evidence base and most published research
has been uncoordinated. The care for these children is
marked by controversies with multiple protocols con-
cerning treatment [3]. Additionally, the care for this
group of children is being delivered in a fragmented way
through several centres in India [2]. In a previous study
looking at the burden of orofacial clefting (OFC), it has
been reported that a total of 79,430 cleft patients had
unmet treatment needs which accounted for 18.76% of
the total Indian cleft population [4].
An alveolar cleft commonly affects 75% of cleft lip and
palate patients [5]. The cleft may influence the position
of the teeth and the dental arches, cause speech
problems, exacerbate facial asymmetry, and result in a
lack of bone support for the anterior teeth [6]. It is now
standard practice to correct this problem by bone
grafting the cleft alveolus before the eruption of the
permanent canines [7]. It is also common clinical
practice to provide a course of orthodontic treatment to
correct any discrepancy between the alveolar segments
and widen the cleft alveolus to improve surgical access.
While it is common practice to provide a course of
orthodontic treatment before alveolar bone grafting, a
recent systematic review of the literature reveals that
most studies underpinning this procedure are
retrospective analyses of case series [5]. Importantly,
there has been no prospective randomised trial on the
benefits and relative costs of this procedure. This has led
to some diversity of practice in India with some Indian
centres carrying out pre bone graft orthodontic
treatment routinely, while others do not.
Rationale
A child undergoing pre-graft orthodontic treatment has
to attend the Cleft Centre over a 6–15-month period, on
amonthly basis and is also subject to the risks of ortho-
dontic treatment, for example, dental decay, gingivitis,
and root resorption [8]. It could be argued that this
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increases the burden of care for the child and parent
and overall treatment costs, particularly if the treatment
extends into the definitive phase of care. Furthermore,
they have to undergo orthodontic treatment at an earlier
age than their peers and may feel ‘set apart’ from their
friends and classmates.
There is a serious lack of research in terms of
comprehensive cleft care of UCLP patients at various
stages of development in India. To our knowledge, there
are no high-quality studies on pre alveolar bone graft or-
thodontics for cleft patients in India. Hence, this pro-
posed study is aimed at evaluating the need for
prealvoelar cleft orthodontics, reducing the burden and
at the same time standardising and improving the qual-
ity of care for these patients.
Methods
Aim
To aim of this study is to compare the effectiveness of
pre alveolar bone graft orthodontic treatment with no
orthodontic treatment for children with unilateral cleft
palate requiring alveolar bone graft surgery.
Objectives
1. To evaluate the effectiveness of pre alveolar bone
graft orthodontic treatment for children with
unilateral cleft palate.
Null hypothesis
The use of pre graft orthodontics is no more effective
than no orthodontic treatment for cleft alveolus patients.
Design
Prealveolar bone graft Orthodontics (PABO) study is a
1:1 parallel group multicentre trial. Children aged
between 8 and 13 will be randomised to either pregraft
orthodontics group or no orthodontic treatment group.
The study design is illustrated in Fig. 1.
Study setting
The trial will be coordinated from Sree Balaji Dental
College, Bharath Institute of Higher Education and
Research, India. The trial will be conducted by cleft
teams based in three centres across India. Criteria for
the selection of sites are based on the previous
experience in research and the volume of patients seen.
The cleft team at each centre will include an
orthodontist, cleft surgeon, paediatrician and cleft nurse.
Eligibility criteria
Patients referred to cleft lip and palate centres will be
included if they satisfy the below inclusion criteria:
 Unilateral cleft alveolus requiring alveolar bone graft
 Upper central incisors erupted.
 Aged 8 and 13 years old
 Written informed consent
 One care/parent must be a native language speaker
of the state of residence.
Patients with any of the following will be excluded
from the study:
 Bilateral cleft palate
 Patients with syndromes or other medical condition
 Subjects involved in any other orthodontic trials
 Inadequate oral hygiene
Enrolment
The surgeon and orthodontist at each centre will assess
the patient for inclusion and exclusion criteria. If the
patient is identified as a potential patient, the parent/
guardian will be invited, and information provided about
the trial and the process of enrolment. The patient
information sheet and consent form will be provided to
the parent/legal guardian and they will then be given
ample time to read and understand the forms and ask
any questions. If the parent declines to participate, they
will receive treatment as current practice and will
receive the same level of support as patients
participating in the trial.
If the parent/guardian agrees to take part, copies of
the signed forms will be made, and one given to the
parents.
Participants will be informed that they can withdraw
from the study at any time without an explanation and
their child’s care will not be affected.
Randomisation
Once the consent is sought and the forms completed, the
participant data will be entered on the central online
randomisation system and the participant will be
randomised using a secure online randomisation system
to either the pregraft orthodontic group or no orthodontic
treatment group, in a 1:1 ratio. The allocation sequence
generation will be generated through the randomisation
programme. The randomisation will be stratified on
gender to get an equal number of males and females. The
participants will be allocated by an independent
researcher blinded to all the study data except to patient
gender. Each participant will then be assigned a unique
randomisation number.
Interventions
Orthodontic treatment will be provided for the
treatment group. The treatment will involve fixed braces
for the top teeth with or without expanders to widen the
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top jaw. The brace technique will be a clinical
judgement and will be done in real-world setting. The
treatment with a fixed brace can take up to 15 months.
This will be followed by alveolar bone graft surgery to
repair the cleft palate. The alveolar bone graft surgery
will be standardised across all surgeons.
In the control group, no orthodontic treatment will be
provided but the patients will have alveolar bone graft
surgery.
The trial will be carried out in a real-world setting and
the patient will not be prohibited from any other care
during the trial.
Blinding
Due to the nature of the intervention, it is not possible
to blind the investigator or the patient. The outcome
assessor, however, will be blinded to the allocated group.
Outcome measures
The primary outcome will be:
 Success of alveolar bone graft assessed from CBCT
and oblique occlusal (Kindelan method)
The secondary outcome measures will be:
 Quality of the dento-occlusal outcome mea-
sured on study models using 10-year-old index
scores
 Qualitative assessment using the validated quality of
life questionnaires
 Breakages
 Quality-adjusted cost analysis
The operator will record a patient as non-compliant if:
Fig. 1 Schematics of trial design
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 Subject refuses to wear the appliance
 Breakage of appliance for more than 3 times
 Measurement indicates a lack of clinical progress
after 9 months of appliance wear
Data collection
Data will be collected at the following points:
▪ T1: At the start of treatment/baseline
▪ T2: 9 months from baseline
▪ T3: Pre alveolar bone graft
▪ T4: 3 months post alveolar bone graft
▪ T5: 6 months post alveolar bone graft
Records, i.e., study models, intra-oral and extra-oral
photographs and a oblique occlusal radiograph will be
taken at each time point. A CBCT will be taken at T5
stage.
In addition, the following data will be collected from
patients’ notes:
 Number of attendances, including failed and
cancelled appointments
 Overall treatment duration
 Frequency of appliance breakages, if any
 Any other emergencies
Patients will be required to fill in the Quality of Life
questionnaires (CPQ8-10) which will inform us how the
appliances will affect them as part of the qualitative
assessment. The CPQ8-10 is a validated questionnaire
and has been used in other orthodontic trials.
Data collection and management
All trial data will be recorded on case report forms
(CRF). The forms from the trial centre will be securely
transported to the data coordinating centre. They will be
entered into a trial specific database by the Trial
Manager at the data coordinating centre.
Radiographs
The oblique occlusal radiographs will be taken at four
time points; start of treatment (T1), prealveolar bone
graft surgery (T3), 3 months post surgery (T4), and 6
months post surgery (T5).
The CBCT radiograph will be taken at the final data
collection point, 6 months post surgery (T5).
The radiographs will be saved with a unique patient
ID and transported to the data coordinating centre using
an encrypted USBs. They will be securely stored onto a
trial-specific computer within the data coordinating
centre.
The SPIRIT checklist for the schedule of enrolment,
interventions, and assessments is shown in Fig. 2.
Study models
The upper and lower impressions along with a wax bite
of occlusion which would be obtained at all time points
and will be casted with dental stone at the trial sites.
The models will then be transported to the data
coordinating centre and stored in a secure site.
Photographs
A set of seven extraoral and eight intraoral photographs
will be obtained at all time points. The photographs will
be saved using a unique study ID on an encrypted USB
and transported to the data coordinating centre.
Data analysis
Sample size estimation
The sample size was based on showing a difference
between groups for the primary outcome, success as
defined by a Grade 1 on the Kindelan bone-fill index.
Based on previous research (Paterson et al.), it is esti-
mated that 60% of the treated will have a successful out-
come. It is estimated that only 25% of the untreated
group will have a successful outcome. With a 5% signifi-
cance level and 80% power, it is calculated that 31 sub-
jects per group, 62 in total are required for the study. To
allow for a 10% non-compliance rate, 72 subjects will be
recruited into the study.
Proposed method to ensure the reliability of measurements
Twenty oblique occlusal radiographs will be evaluated
with Kindelan index, a week apart to ensure good
reliability of the measurement. The Error will be
evaluated with the paired t test, Bland and Altmann and
intra-class correlation coefficient to test both systemic
and random errors.
The trial will be conducted in line with Declaration of
Helsinki (1964) and reported using the Consolidated
Standard of Reporting Trials (CONSORT).
Data analysis
Data will be analysed by an independent statistician. A
detailed analysis will be planned before the final analysis
of the trial. The main features of the statistical plan are
mentioned here.
Data analysis will be carried out at the end of the
study.
The primary outcome, Kindelan bone-fill index, is an
ordinal measure and will be compared between groups
using the Mann-Whitney test. Additionally, the outcome
will be categorised as successful (grade 1) or unsuccess-
ful (grades 2–4). The chi-square test will be used to
compare the categorised outcome between groups.
Independent sample t test and 95% confidence
intervals will be used for all continuous outcomes, for
comparison between the groups. The dichotomous
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outcomes will be compared using chi-square test and
the effect estimates will be reported using relative risk
and 95% confidence interval. The qualitative outcomes
will be compared using chi-square test.
A multivariable linear regression analysis will be
carried out to assess the effect of pre-treatment com-
plexity, gender and orthodontic treatment on the overall
quality of alveolar bone graft success. The primary ana-
lysis will be on an intention-to-treat principle; the results
of all subjects will be accounted for, regardless of the
outcome of the treatment.
Protocol deviations
▪ All patients failing an appointment will be sent
another.
▪ Those wishing to withdraw from the trial may do so
at any point with no detriment to their continuing
treatment. When a patient withdraws from the study
the relevant records will be taken at the point of
withdrawal.
▪ Appliance breakage—every effort will be made for the
patient to be seen by a principal operator. However, in
certain circumstances, the patient may be seen by a
second investigator.
▪ If there are more than four breakages for any one
patient, then the patient will be removed from the
study and records taken at the final breakage
appointment.
Data access
The investigators and the investigators’ designated staff
personnel will have access to their centre’s data. All data
collected will be analysed by an independent statistician.
Subject identifiable data will remain confidential. Access
to subject data and research data will be restricted per
applicable data protection laws/regulations and research
requirements.
Protocol compliance
Accidental protocol deviations can happen at any time.
They will be adequately documented on the relevant
Fig. 2 SPIRIT checklist for the schedule of enrolment, interventions and assessments
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forms and reported to the Chief Investigator
immediately.
Deviations from the protocol which are found to
frequently recur are not acceptable and will require
immediate action, as may be defined as serious breaches.
All potential protocol deviations/violations will be
reported in line with institutional requirements.
Recruitment strategy
A dedicated clinical recruiter will be available at each
site to identify potential participants and alert the
investigators. Additionally, the clinical recruiter will also
have access to the database to identify patients requiring
an alveolar bone graft. Written leaflets with inclusion
criteria will be put up on the clinic waiting room
educating patients on the clinical trial.
Confidentiality
All CRFs will have a unique patient ID allocated upon
randomisation. The DCC will preserve the
confidentiality of the participants taking part in the trial.
The Indian Data Protection Law 2019 and all ICMR
guidelines will be followed in this trial.
Trial monitoring
The study will be overseen by a Study Advisory Group
with nominations from the Cleft Lip and Palate Society
in India. This will include the members of the study
team in addition to an independent chairperson and
independent experts in cleft orthodontics, cleft surgery
and biostatistics. We will also include patient
representatives from Sree Balaji Dental College, BIHER.
The Study Advisory Group will have the following
specific roles (i) regularly provide advice into the study,
(ii) advise on key parameters to explore the Value of
Information analysis, and (iii) advise on the qualitative
component to enable parents and patients to voice their
perspectives and priorities.
Data and Safety Monitoring Board (DSMB)
The DSMB will comprise of a clinician, a statistician and
a layperson. The DSMB will be responsible for reviewing
and assessing recruitment, interim monitoring of safety,
trial conduct and external data.
Ethics
The protocol has gained a favourable opinion from the
Bharath Institute of Higher Education and Research
(SBDCH/IEC/12/2019/2). Current trial status and
timeline: The ethical approval was obtained on 18th
December 2019. The trial recruitment will commence
from 1st November 2020. The recruitment is planned
for 12 months and the data collection is likely to last for
24 months from the last recruited patient.
Ancillary and post-trial care
This will be in accordance with the Indian Council of
Medical research guidelines.
insurance would be covering all patients participating
in the trial for trial-related harms.
The study is a real-world study and is carried out as
we would do for patients routinely seen in clinical care.
The care for these patients post trial will continue as it
would for patients seen routinely in the clinic.
Dissemination
The trial principal investigator will publish the results of
the study in a peer-reviewed scientific journal and pre-
sented at the national and international conference. The
results from the proposed study will be used for discus-
sions with stakeholders and policymakers. Support will
be requested from both for communicating the study re-
sults, and any clinical guidance that stems out from this
project to the general public.
Discussion
The PABO study has the goal of reducing the burden of
care for patients with cleft palate. These children
undergo treatment from different specialists at various
timepoints in their life. Orthodontic treatment is a
lengthy course of treatment and to add this in addition
to other orthodontic treatments in the later part of their
lives along with the already increased burden of care
from other problems must be justified. This early
orthodontic treatment is mainly carried out to make the
alveolar bone graft surgery less complicated and to a
minimal extent, align the front teeth for aesthetic
reasons. However, if this can be avoided with no
compromise on the quality of overall outcome at the of
surgery will be a huge benefit for these patients. This
study will allow us to explore the effectiveness of pre
graft orthodontic treatment and inform both clinicians
and patients on the most effective way of treatment for
children with unilateral cleft palate.
Trial status
Recruitment start date 01/08/2021. Estimated
completion date: 01/08/2022.
Protocol version number 3.3.
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